GTS Securities’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,294
Closed -$156K 1283
2025
Q1
$156K Buy
12,294
+468
+4% +$7.35K 0.01% 1159
2024
Q4
$260K Sell
11,826
-74,410
-86% -$1.56M 0.01% 974
2024
Q3
$1.54M Buy
86,236
+33,079
+62% +$530K ﹤0.01% 1773
2024
Q2
$853K Buy
53,157
+30,073
+130% +$475K ﹤0.01% 2204
2024
Q1
$343K Sell
23,084
-13,835
-37% -$220K ﹤0.01% 2887
2023
Q4
$660K Sell
36,919
-6,319
-15% -$102K ﹤0.01% 2549
2023
Q3
$826K Buy
43,238
+15,412
+55% +$267K ﹤0.01% 2165
2023
Q2
$441K Buy
+27,826
New +$458K 0.01% 712

Other funds holding CLMT

GTS Securities's CLMT Position: Q2 2025 in Review

GTS Securities sold out of Calumet Specialty Products (CLMT) in Q2 2025, closing a stake of 12,294 shares — an estimated $156K sold.

GTS Securities first reported a position in CLMT in Q2 2023 and held it in 8 quarters. The position peaked at $1.54M in Q3 2024. 134 funds tracked by Wall St. Rank hold CLMT as of Q2 2025.

  • GTS Securities reported no remaining Calumet Specialty Products position as of Q2 2025 after selling out during the quarter.
  • GTS Securities sold 12,294 Calumet Specialty Products shares in Q2 2025, an estimated $156K.
  • GTS Securities first reported a position in Calumet Specialty Products in Q2 2023 and held it in 8 quarters.
  • GTS Securities's Calumet Specialty Products position peaked at $1.54M in Q3 2024.
  • 134 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.